Biomarkers for physical frailty and sarcopenia
Physical frailty (PF) and sarcopenia are major health issues in geriatric populations, given
their high prevalence and association with several adverse outcomes. Nevertheless, the …
their high prevalence and association with several adverse outcomes. Nevertheless, the …
Biomarkers for physical frailty and sarcopenia
R Calvani, F Marini, M Cesari, M Tosato… - Aging Clinical and …, 2017 - infona.pl
Physical frailty (PF) and sarcopenia are major health issues in geriatric populations, given
their high prevalence and association with several adverse outcomes. Nevertheless, the …
their high prevalence and association with several adverse outcomes. Nevertheless, the …
[PDF][PDF] Biomarkers for physical frailty and sarcopenia
R Calvani, F Marini, M Cesari, M Tosato… - Aging Clin Exp …, 2017 - publicatt.unicatt.it
Accepted: 10 October 2016/Published online: 2 February 2017© Springer International
Publishing Switzerland 2017 phenotypical and pathophysiological complexity of PF and …
Publishing Switzerland 2017 phenotypical and pathophysiological complexity of PF and …
Biomarkers for physical frailty and sarcopenia.
R Calvani, F Marini, M Cesari, M Tosato… - Aging Clinical and …, 2017 - europepmc.org
Physical frailty (PF) and sarcopenia are major health issues in geriatric populations, given
their high prevalence and association with several adverse outcomes. Nevertheless, the …
their high prevalence and association with several adverse outcomes. Nevertheless, the …
Biomarkers for physical frailty and sarcopenia
R Calvani, F Marini, M Cesari, M Tosato… - AGING CLINICAL AND …, 2017 - iris.uniroma1.it
Physical frailty (PF) and sarcopenia are major health issues in geriatric populations, given
their high prevalence and association with several adverse outcomes. Nevertheless, the …
their high prevalence and association with several adverse outcomes. Nevertheless, the …
[引用][C] Biomarkers for physical frailty and sarcopenia
R Calvani, F Marini, M Cesari, M Tosato, A Picca… - 2017 - publications.goettingen-research …
Biomarkers for physical frailty and sarcopenia
R Calvani, F Marini, M Cesari… - Aging clinical and …, 2017 - pubmed.ncbi.nlm.nih.gov
Physical frailty (PF) and sarcopenia are major health issues in geriatric populations, given
their high prevalence and association with several adverse outcomes. Nevertheless, the …
their high prevalence and association with several adverse outcomes. Nevertheless, the …
Biomarkers for physical frailty and sarcopenia
C Riccardo, M Federico, C Matteo… - Aging Clinical and …, 2017 - search.proquest.com
Physical frailty (PF) and sarcopenia are major health issues in geriatric populations, given
their high prevalence and association with several adverse outcomes. Nevertheless, the …
their high prevalence and association with several adverse outcomes. Nevertheless, the …
Biomarkers for physical frailty and sarcopenia
R Calvani, F Marini, M Cesari, M Tosato… - AGING CLINICAL AND …, 2017 - air.unimi.it
Physical frailty (PF) and sarcopenia are major health issues in geriatric populations, given
their high prevalence and association with several adverse outcomes. Nevertheless, the …
their high prevalence and association with several adverse outcomes. Nevertheless, the …
Biomarkers for physical frailty and sarcopenia
R Calvani, F Marini, M Cesari, M Tosato… - AGING CLINICAL AND …, 2017 - ricerca.lum.it
Physical frailty (PF) and sarcopenia are major health issues in geriatric populations, given
their high prevalence and association with several adverse outcomes. Nevertheless, the …
their high prevalence and association with several adverse outcomes. Nevertheless, the …